Clinical Trial Update: Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating cognitive behavioral therapy, modafinil, or both for fatigue in people with multiple sclerosis; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Cognitive behavioral therapy
• Modafinil (modafinil)

Snippet

Sponsor: University of Michigan | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2022-12-27